Researchers found that during the earliest phases of infection, the reservoir is quite susceptible to antiretroviral treatment.

Researchers attribute this dramatic shift to routine testing and access to direct-acting antiviral treatment for hep C.

A recent Japanese study found that this risk reduction was greater than that associated with the hep B vaccine.

Researchers found that among those older than 50, lung function declined at a comparable rate regardless of HIV status.

The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.

Researchers found that the more people with HIV drank, the lower a biomarker of bone formation.

New York City’s department of health issues recommendations on navigating sex when social distancing is the name of the game.

The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.

Alabama state pandemic guidance advises denying ventilators for use by people with metastatic cancer, AIDS and end-stage liver disease.